Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2023 | 105 | 4.920 |
Why?
|
| Huntington Disease | 8 | 2022 | 28 | 3.120 |
Why?
|
| Myotonic Dystrophy | 7 | 2023 | 13 | 3.020 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2023 | 182 | 2.990 |
Why?
|
| Survivors | 7 | 2023 | 137 | 1.910 |
Why?
|
| Brain | 15 | 2023 | 1391 | 1.910 |
Why?
|
| Cleft Lip | 5 | 2021 | 37 | 1.600 |
Why?
|
| Cleft Palate | 5 | 2021 | 72 | 1.530 |
Why?
|
| Child | 32 | 2023 | 7372 | 1.490 |
Why?
|
| Cognition | 4 | 2023 | 349 | 1.330 |
Why?
|
| Neuropsychological Tests | 4 | 2021 | 363 | 1.250 |
Why?
|
| Adolescent | 24 | 2022 | 6896 | 1.200 |
Why?
|
| Memory, Short-Term | 5 | 2022 | 85 | 1.150 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 1616 | 1.120 |
Why?
|
| Leg | 3 | 2023 | 130 | 1.010 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 189 | 0.970 |
Why?
|
| Adolescent Development | 2 | 2020 | 20 | 0.950 |
Why?
|
| Intelligence | 2 | 2020 | 63 | 0.900 |
Why?
|
| Male | 33 | 2023 | 27335 | 0.890 |
Why?
|
| Neuroimaging | 3 | 2021 | 88 | 0.880 |
Why?
|
| Facial Expression | 2 | 2020 | 14 | 0.880 |
Why?
|
| Neurofilament Proteins | 2 | 2022 | 3 | 0.870 |
Why?
|
| Child Development | 3 | 2020 | 204 | 0.840 |
Why?
|
| Humans | 46 | 2023 | 54304 | 0.820 |
Why?
|
| Glucocorticoids | 1 | 2023 | 234 | 0.790 |
Why?
|
| Adolescent Behavior | 2 | 2020 | 113 | 0.770 |
Why?
|
| Female | 29 | 2023 | 28457 | 0.760 |
Why?
|
| Executive Function | 5 | 2023 | 80 | 0.750 |
Why?
|
| Child Behavior | 1 | 2020 | 114 | 0.720 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2019 | 5 | 0.690 |
Why?
|
| Psychomotor Performance | 2 | 2016 | 156 | 0.640 |
Why?
|
| Quality of Life | 2 | 2020 | 922 | 0.600 |
Why?
|
| Motor Activity | 1 | 2019 | 246 | 0.600 |
Why?
|
| Body Height | 2 | 2020 | 76 | 0.590 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1229 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 571 | 0.560 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2016 | 43 | 0.560 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1300 | 0.510 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 847 | 0.500 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 231 | 0.480 |
Why?
|
| Body Mass Index | 2 | 2020 | 705 | 0.470 |
Why?
|
| Amygdala | 2 | 2011 | 40 | 0.460 |
Why?
|
| Young Adult | 10 | 2022 | 4313 | 0.460 |
Why?
|
| Social Isolation | 1 | 2013 | 29 | 0.460 |
Why?
|
| Cognition Disorders | 2 | 2020 | 240 | 0.450 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 1693 | 0.430 |
Why?
|
| Adult | 13 | 2023 | 14189 | 0.410 |
Why?
|
| Pituitary Gland | 1 | 2012 | 78 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2023 | 256 | 0.400 |
Why?
|
| Motivation | 1 | 2013 | 289 | 0.380 |
Why?
|
| Neoplasms | 1 | 2021 | 1321 | 0.380 |
Why?
|
| Sex Characteristics | 2 | 2010 | 213 | 0.380 |
Why?
|
| Emotions | 2 | 2020 | 170 | 0.350 |
Why?
|
| Fear | 1 | 2010 | 87 | 0.340 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 162 | 0.330 |
Why?
|
| Reaction Time | 3 | 2020 | 227 | 0.330 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2008 | 125 | 0.300 |
Why?
|
| Middle Aged | 6 | 2021 | 13076 | 0.290 |
Why?
|
| Corpus Striatum | 3 | 2022 | 67 | 0.280 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 246 | 0.270 |
Why?
|
| Alcoholism | 1 | 2008 | 249 | 0.270 |
Why?
|
| Anisotropy | 2 | 2023 | 64 | 0.260 |
Why?
|
| Intermediate Filaments | 2 | 2022 | 5 | 0.260 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2023 | 97 | 0.250 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 742 | 0.250 |
Why?
|
| Reading | 2 | 2021 | 84 | 0.240 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2023 | 6 | 0.230 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2023 | 9 | 0.230 |
Why?
|
| Child, Preschool | 3 | 2021 | 4161 | 0.230 |
Why?
|
| Functional Neuroimaging | 1 | 2023 | 25 | 0.230 |
Why?
|
| Movement Disorders | 1 | 2022 | 19 | 0.220 |
Why?
|
| Folic Acid | 1 | 2023 | 139 | 0.220 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 7 | 0.210 |
Why?
|
| Risk Factors | 2 | 2021 | 3934 | 0.210 |
Why?
|
| Trinucleotide Repeats | 1 | 2021 | 3 | 0.200 |
Why?
|
| Kidney Failure, Chronic | 1 | 2023 | 232 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 128 | 0.190 |
Why?
|
| Motor Skills | 1 | 2020 | 31 | 0.190 |
Why?
|
| Dyslexia | 1 | 2021 | 56 | 0.190 |
Why?
|
| Kidney | 2 | 2023 | 821 | 0.190 |
Why?
|
| Sex Factors | 2 | 2020 | 766 | 0.180 |
Why?
|
| Mutation | 3 | 2022 | 1504 | 0.170 |
Why?
|
| Genetic Testing | 1 | 2019 | 135 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2021 | 614 | 0.160 |
Why?
|
| Leukemia | 1 | 2018 | 69 | 0.160 |
Why?
|
| Intelligence Tests | 1 | 2017 | 44 | 0.160 |
Why?
|
| Infant | 3 | 2021 | 3832 | 0.150 |
Why?
|
| Problem Solving | 1 | 2017 | 46 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2019 | 398 | 0.150 |
Why?
|
| Body Weight | 1 | 2020 | 574 | 0.150 |
Why?
|
| Educational Status | 2 | 2020 | 261 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 1200 | 0.150 |
Why?
|
| Anxiety | 2 | 2022 | 279 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2018 | 184 | 0.140 |
Why?
|
| Siblings | 1 | 2016 | 38 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2020 | 1361 | 0.130 |
Why?
|
| Organ Size | 2 | 2020 | 237 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2018 | 239 | 0.130 |
Why?
|
| Aging | 1 | 2021 | 782 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2021 | 2604 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2023 | 6462 | 0.120 |
Why?
|
| Galvanic Skin Response | 1 | 2013 | 24 | 0.120 |
Why?
|
| Feedback, Psychological | 1 | 2013 | 20 | 0.120 |
Why?
|
| Eye Movements | 1 | 2013 | 26 | 0.110 |
Why?
|
| Phenotype | 1 | 2016 | 820 | 0.110 |
Why?
|
| Social Perception | 1 | 2013 | 32 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2013 | 99 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 3430 | 0.110 |
Why?
|
| Brain Damage, Chronic | 1 | 2011 | 14 | 0.100 |
Why?
|
| Muscles | 2 | 2023 | 114 | 0.100 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 243 | 0.100 |
Why?
|
| Psychological Tests | 1 | 2010 | 53 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 233 | 0.090 |
Why?
|
| Aged | 2 | 2021 | 10054 | 0.090 |
Why?
|
| Disease Progression | 2 | 2022 | 915 | 0.090 |
Why?
|
| Risk-Taking | 1 | 2008 | 126 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2008 | 634 | 0.070 |
Why?
|
| Reward | 1 | 2008 | 123 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2008 | 94 | 0.070 |
Why?
|
| Prefrontal Cortex | 2 | 2022 | 89 | 0.070 |
Why?
|
| Decision Making | 1 | 2008 | 286 | 0.070 |
Why?
|
| Neostriatum | 1 | 2022 | 13 | 0.050 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2023 | 193 | 0.050 |
Why?
|
| Methotrexate | 1 | 2022 | 73 | 0.050 |
Why?
|
| Fatigue | 1 | 2022 | 128 | 0.050 |
Why?
|
| Visual Perception | 1 | 2021 | 42 | 0.050 |
Why?
|
| Verbal Behavior | 1 | 2021 | 35 | 0.050 |
Why?
|
| Language Development | 1 | 2021 | 31 | 0.050 |
Why?
|
| Heterozygote | 1 | 2021 | 96 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2020 | 27 | 0.050 |
Why?
|
| Speech Disorders | 1 | 2020 | 18 | 0.050 |
Why?
|
| Cerebrum | 1 | 2020 | 11 | 0.050 |
Why?
|
| Mathematics | 1 | 2020 | 47 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 188 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 139 | 0.050 |
Why?
|
| Social Class | 1 | 2020 | 109 | 0.040 |
Why?
|
| Cerebellum | 1 | 2020 | 142 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 343 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2018 | 14 | 0.040 |
Why?
|
| Brain Mapping | 2 | 2011 | 250 | 0.040 |
Why?
|
| Mothers | 1 | 2020 | 248 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 805 | 0.040 |
Why?
|
| Echocardiography | 1 | 2018 | 392 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1651 | 0.030 |
Why?
|
| Games, Experimental | 1 | 2008 | 11 | 0.020 |
Why?
|
| Punishment | 1 | 2008 | 19 | 0.020 |
Why?
|
| Peer Group | 1 | 2008 | 58 | 0.020 |
Why?
|
| Cues | 1 | 2008 | 55 | 0.020 |
Why?
|
| Mice | 1 | 2018 | 6428 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 14402 | 0.010 |
Why?
|